Neurologist rises to challenge of Alzheimer's Disease diagnosis
Posted on 9 January 2006
Professor John Hodges, Professor of Behavioural Neurology at Cambridge University will give the Alzheimer's Research Trust lecture at 6.30pm on 16 January 2006.
The lecture, which is free and open to all, is in the Physics Building Lecture Theatre (P/L001) on the University of York's Heslington Campus. It is organised in association with the University's Department of Psychology and the Clinical Neuroscience Centre at the University of Hull.
Professor Hodges is Professor of Behavioural Neurology at the Medical Research Council (MRC) Cognition and Brain Sciences Unit and the University Department of Neurology in Cambridge.
He has a particular interest in memory, language and early onset dementia syndromes, and directs Memory and the Early Onset Dementia Clinics at Addenbrooke's Hospital, Cambridge. Professor Hodges co-ordinates a research team consisting of neuropsychologists, behavioural neurologists and neuroimagers and is also heavily involved in carer support.
Next month, members of the public are invited to attend a second lecture, taking place at 6:30pm on 14 February 2006 at the Guildhall, Hull.
Professor Clive Ballard, Chairman of the Alzheimer's Society and Professor of Age Related Diseases at King's College London, will give the lecture on 'Endogenous Stem Cells in Dementia', demonstrating his extensive knowledge and research related to the disease and the development of treatment targets.
Notes to editors:
- The Department of Psychology at the University of York has one of the strongest and most consistent track records in research in the UK. Since the inception of the UK Research Assessment Exercise the Department has been classified in the highest category for research along with the departments at Oxford, Cambridge and St. Andrews. Currently the Department is ranked a 5*A.
- The Alzheimer's Research Trust is the leading charity funding UK research into Alzheimer's disease and related dementias. The Trust also provides information on the disease to both the public and the medical community.